$RMNI
Rimini Street, Inc.

2017 Q3 Form 10-Q Financial Statement

#000114420417052918 Filed on October 18, 2017

View on sec.gov

Income Statement

Concept 2017 Q3 2016 Q4 2016 Q3
Revenue $53.61M $46.74M $40.72M
YoY Change 31.65% -60.46%
Cost Of Revenue $20.11M $18.97M $17.23M
YoY Change 16.7% -64.07%
Gross Profit $33.50M $27.77M $23.49M
YoY Change 42.61% -57.54%
Gross Profit Margin 62.49% 59.41% 57.69%
Selling, General & Admin $25.77M $31.49M $26.92M
YoY Change -4.27% -57.78% 26817.0%
% of Gross Profit 76.91% 113.42% 114.58%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $510.0K $1.780M
YoY Change 22.76%
% of Gross Profit 1.52% 6.41%
Operating Expenses $26.13M $31.49M $26.92M
YoY Change -2.91% -57.73% 26817.0%
Operating Profit $7.369M $37.93M -$4.506M
YoY Change -263.54% -516.76% 5451.86%
Interest Expense $9.152M $8.336M $4.317M
YoY Change 112.0% -1026.22%
% of Operating Profit 124.2% 21.98%
Other Income/Expense, Net $108.0K -$1.121M -$144.0K
YoY Change -175.0% 1.91%
Pretax Income -$8.655M $24.70M -$15.09M
YoY Change -42.63% -156.26% 14985.0%
Income Tax $385.0K -$637.0K -$306.0K
% Of Pretax Income -2.58%
Net Earnings -$9.040M $24.06M -$15.39M
YoY Change -41.26% -153.11% 29596.88%
Net Earnings / Revenue -16.86% 51.48% -37.79%
Basic Earnings Per Share -$0.37 $0.58 -$0.63
Diluted Earnings Per Share -$0.37 $0.31 -$0.63
COMMON SHARES
Basic Shares Outstanding 24.73M shares 24.27M shares 24.26M shares
Diluted Shares Outstanding 24.73M shares 45.26M shares 24.26M shares

Balance Sheet

Concept 2017 Q3 2016 Q4 2016 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $0.00 $9.400M $0.00
YoY Change 840.0% -100.0%
Cash & Equivalents $15.59M $9.385M $2.470K
Short-Term Investments
Other Short-Term Assets $0.00 $24.60M $200.0K
YoY Change -100.0%
Inventory
Prepaid Expenses $5.748M $233.9K
Receivables $55.32M
Other Receivables $0.00
Total Short-Term Assets $0.00 $89.31M $236.4K
YoY Change -100.0% 9056.14% -78.51%
LONG-TERM ASSETS
Property, Plant & Equipment $4.559M
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $158.2M $5.500M $173.0M
YoY Change -8.55% -96.81% 0.23%
Total Long-Term Assets $158.2M $10.07M $173.0M
YoY Change -8.54% -94.17% 0.26%
TOTAL ASSETS
Total Short-Term Assets $0.00 $89.31M $236.4K
Total Long-Term Assets $158.2M $10.07M $173.0M
Total Assets $158.2M $99.38M $173.2M
YoY Change -8.67% -42.74% -0.24%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $200.0K $8.839M $400.0K
YoY Change -50.0%
Accrued Expenses $63.01K $379.7K
YoY Change 215.55% 1767.99%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $24.75M
YoY Change
Total Short-Term Liabilities $246.0K $212.9M $7.600M
YoY Change -96.76% 1066266.19% 24.59%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $63.31M $0.00
YoY Change
Other Long-Term Liabilities $9.000M $36.60M
YoY Change
Total Long-Term Liabilities $9.000M $63.31M $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $246.0K $212.9M $7.600M
Total Long-Term Liabilities $9.000M $63.31M $0.00
Total Liabilities $9.300M $8.636M $7.610M
YoY Change 22.21% 42.57% 25.62%
SHAREHOLDERS EQUITY
Retained Earnings -$251.1M -$2.028M
YoY Change 191988.8% 3325.66%
Common Stock $2.000K $554.00
YoY Change 275.94% 4.33%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $149.0M -$180.6M $5.000M
YoY Change
Total Liabilities & Shareholders Equity $158.2M $99.38M $173.2M
YoY Change -8.67% -42.74% -0.24%

Cashflow Statement

Concept 2017 Q3 2016 Q4 2016 Q3
OPERATING ACTIVITIES
Net Income -$9.040M $24.06M -$15.39M
YoY Change -41.26% -153.11% 29596.88%
Depreciation, Depletion And Amortization $510.0K $1.780M
YoY Change 22.76%
Cash From Operating Activities -$4.360M -$57.45M -$940.0K
YoY Change 363.83% -3499.41% 1242.86%
INVESTING ACTIVITIES
Capital Expenditures -$170.0K -$1.190M
YoY Change -32.0%
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change
Cash From Investing Activities -$170.0K -$1.190M $0.00
YoY Change -100.7%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -8.070M 75.90M 800.0K
YoY Change -1108.75% -143.5%
NET CHANGE
Cash From Operating Activities -4.360M -57.45M -940.0K
Cash From Investing Activities -170.0K -1.190M 0.000
Cash From Financing Activities -8.070M 75.90M 800.0K
Net Change In Cash -12.60M 17.26M -140.0K
YoY Change 8900.0% -937.86% 100.0%
FREE CASH FLOW
Cash From Operating Activities -$4.360M -$57.45M -$940.0K
Capital Expenditures -$170.0K -$1.190M
Free Cash Flow -$4.190M -$56.26M
YoY Change -1735.47%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2016Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1551 USD
CY2016Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-2991891 USD
CY2016Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
7991327 USD
CY2016Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2016Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
159635018 USD
CY2017Q3 us-gaap Notes Payable Related Parties Noncurrent
NotesPayableRelatedPartiesNoncurrent
2980631 USD
CY2016Q4 us-gaap Notes Payable Related Parties Noncurrent
NotesPayableRelatedPartiesNoncurrent
1900000 USD
CY2017Q3 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
57140 USD
CY2016Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
635681 USD
CY2017Q3 us-gaap Liabilities Current
LiabilitiesCurrent
245974 USD
CY2016Q4 us-gaap Liabilities Current
LiabilitiesCurrent
698690 USD
CY2017Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-348224 USD
CY2017Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
313290 USD
CY2017Q3 us-gaap Net Income Loss
NetIncomeLoss
-37618 USD
CY2016Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
217668 USD
CY2016Q4 us-gaap Assets Current
AssetsCurrent
219219 USD
CY2016Q4 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
173051990 USD
CY2016Q4 us-gaap Assets
Assets
173271209 USD
CY2016Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
63009 USD
CY2016Q4 us-gaap Deferred Long Term Liability Charges
DeferredLongTermLiabilityCharges
6037500 USD
CY2016Q4 us-gaap Liabilities
Liabilities
8636190 USD
CY2016Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
173271209 USD
CY2016Q4 us-gaap Stockholders Equity
StockholdersEquity
5000001 USD
CY2017Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.01
CY2016Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-402948 USD
CY2016Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
55234 USD
CY2016Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
5506671 shares
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
831833 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-831833 USD
us-gaap Investment Income Interest
InvestmentIncomeInterest
393573 USD
us-gaap Net Income Loss
NetIncomeLoss
-67032 USD
us-gaap Net Income Loss
NetIncomeLoss
-1897194 USD
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
2291424 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-2291424 USD
us-gaap Investment Income Interest
InvestmentIncomeInterest
764801 USD
CY2017Q3 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
143959790 USD
CY2015Q2 us-gaap Due To Affiliate Current
DueToAffiliateCurrent
10000 USD
CY2016Q3 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
402948 USD
CY2016Q3 us-gaap Net Income Loss
NetIncomeLoss
-347057 USD
CY2016Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.06
CY2017Q3 us-gaap Due To Affiliate Current
DueToAffiliateCurrent
150000 USD
CY2016Q4 us-gaap Common Stock Value
CommonStockValue
565 USD
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
5417696 shares
CY2016Q4 us-gaap Due To Affiliate Current
DueToAffiliateCurrent
60000 USD
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-203918 USD
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
5670416 shares
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.01
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.35
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
125825 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-502090 USD
CY2015Q2 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
172500000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-15106106 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
0 USD
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
444950 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
359775 USD
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
225966 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2157615 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1192636 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-964979 USD
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
967449 USD
CY2016Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2470 USD
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
1192636 USD
rmni Change In Value Of Common Stock Subject To Possible Redemption
ChangeInValueOfCommonStockSubjectToPossibleRedemption
-67032 USD
rmni Change In Value Of Common Stock Subject To Possible Redemption
ChangeInValueOfCommonStockSubjectToPossibleRedemption
1897194 USD
rmni Reclassification Of Related Party Advances To Related Party Promissory Notes
ReclassificationOfRelatedPartyAdvancesToRelatedPartyPromissoryNotes
635681 USD
rmni Reclassification Of Related Party Advances To Related Party Promissory Notes
ReclassificationOfRelatedPartyAdvancesToRelatedPartyPromissoryNotes
0 USD
us-gaap Proceeds From Decommissioning Fund
ProceedsFromDecommissioningFund
15608196 USD
us-gaap Proceeds From Decommissioning Fund
ProceedsFromDecommissioningFund
0 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
15608196 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
15608196 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
0 USD
dei Entity Incorporation Date Of Incorporation
EntityIncorporationDateOfIncorporation
2015-01-28
CY2015Q2 rmni Common Units Issued In Initial Public Offering
CommonUnitsIssuedInInitialPublicOffering
17250000 shares
CY2015Q2 us-gaap Other Ownership Interests Offering Costs
OtherOwnershipInterestsOfferingCosts
10960590 USD
CY2015Q2 us-gaap Expense Related To Distribution Or Servicing And Underwriting Fees
ExpenseRelatedToDistributionOrServicingAndUnderwritingFees
4312500 USD
CY2015Q2 us-gaap Deferred Offering Costs
DeferredOfferingCosts
6037500 USD
CY2017Q2 us-gaap Treasury Stock Shares Retired
TreasuryStockSharesRetired
1552724 shares
CY2017Q2 us-gaap Treasury Stock Retired Cost Method Amount
TreasuryStockRetiredCostMethodAmount
15608196 USD
CY2017Q2 us-gaap Temporary Equity Redemption Price Per Share
TemporaryEquityRedemptionPricePerShare
10.05
CY2017Q3 us-gaap Assets Held In Trust Current
AssetsHeldInTrustCurrent
158208595 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
14687500 shares
CY2017Q3 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000 USD
CY2017Q3 us-gaap Administrative Fees Expense
AdministrativeFeesExpense
30000 USD
us-gaap Administrative Fees Expense
AdministrativeFeesExpense
90000 USD
CY2016Q4 us-gaap Due To Other Related Parties Classified Current
DueToOtherRelatedPartiesClassifiedCurrent
635681 USD
CY2017Q3 us-gaap Debt Instrument Unused Borrowing Capacity Amount
DebtInstrumentUnusedBorrowingCapacityAmount
3400000 USD
CY2017Q3 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
3400000 USD
CY2017Q3 rmni Contingent Transaction Fee Amount
ContingentTransactionFeeAmount
3993000 USD
CY2015Q2 rmni Underwriters Discount Percentage
UnderwritersDiscountPercentage
0.060 pure
CY2015Q2 rmni Payments To Underwriters In Cash
PaymentsToUnderwritersInCash
4312500 USD
CY2015Q2 rmni Underwriters Deferred Discount Amount
UnderwritersDeferredDiscountAmount
6037500 USD
CY2017Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000000 shares
CY2017Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2017Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1000000000 shares
CY2017Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2017Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5726251 shares
CY2017Q3 us-gaap Common Stock Other Shares Outstanding
CommonStockOtherSharesOutstanding
14283525 shares
CY2016Q4 us-gaap Common Stock Other Shares Outstanding
CommonStockOtherSharesOutstanding
15912582 shares
CY2017Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2016Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2017Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2016Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2017Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2016Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2016Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2016Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000000 shares
CY2016Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2016Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1000000000 shares
CY2017Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5726251 shares
CY2016Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5649918 shares
CY2016Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5649918 shares
CY2017Q3 us-gaap Gain Loss On Sale Of Securities Net
GainLossOnSaleOfSecuritiesNet
-2684 USD
CY2016Q3 us-gaap Gain Loss On Sale Of Securities Net
GainLossOnSaleOfSecuritiesNet
657 USD
us-gaap Gain Loss On Sale Of Securities Net
GainLossOnSaleOfSecuritiesNet
0 USD
us-gaap Gain Loss On Sale Of Securities Net
GainLossOnSaleOfSecuritiesNet
657 USD
CY2016Q3 us-gaap Common Stock Other Shares Outstanding
CommonStockOtherSharesOutstanding
16016030 shares
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
57140 USD
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
0 USD
rmni Underwriters Deferred For Services Cash Settled Amount
UnderwritersDeferredForServicesCashSettledAmount
4429306 USD
us-gaap Administrative Fees Expense
AdministrativeFeesExpense
90000 USD
us-gaap Use Of Estimates
UseOfEstimates
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><b><i><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>Use of estimates</i></b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 31.9pt; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 31.9pt; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future events. Accordingly, the actual results could differ significantly from those estimates.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><b><i><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>Concentration of credit risk</i></b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 27.5pt; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">Financial instruments that potentially subject the Company to concentration of credit risk consist of cash accounts in a financial institution which, at times may exceed the Federal depository insurance coverage of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">250,000</font>. At September 30, 2017 and December 31, 2016, the Company had not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts.<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2016Q3 us-gaap Administrative Fees Expense
AdministrativeFeesExpense
30000 USD

Files In Submission

Name View Source Status
0001144204-17-052918-index-headers.html Edgar Link pending
0001144204-17-052918-index.html Edgar Link pending
0001144204-17-052918.txt Edgar Link pending
0001144204-17-052918-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
rmni-20170930.xml Edgar Link completed
rmni-20170930.xsd Edgar Link pending
rmni-20170930_cal.xml Edgar Link unprocessable
rmni-20170930_def.xml Edgar Link unprocessable
rmni-20170930_lab.xml Edgar Link unprocessable
rmni-20170930_pre.xml Edgar Link unprocessable
Show.js Edgar Link pending
tv477000_10q.htm Edgar Link pending
tv477000_ex31-1.htm Edgar Link pending
tv477000_ex31-2.htm Edgar Link pending
tv477000_ex32-1.htm Edgar Link pending
tv477000_ex32-2.htm Edgar Link pending